Literature DB >> 19434342

Live or let die: ethical issues in a psychiatric patient with end-stage renal failure.

Aaron Ang1, Peter C W Loke, Alastair V Campbell, Siow Ann Chong.   

Abstract

Medical co-morbidities are very common in patients with psychiatric conditions. Although respecting one's autonomy to make treatment decisions is the ethical default position, the capacity to make such decisions may need to be assessed, especially when patients are in relapse of their psychiatric condition, and/or when the decisions made are high-risk and possibly fatal. This case report highlights the ethical issues of refusing potential life-saving treatment in a patient who is in relapse of her schizoaffective disorder. In particular, the assessment of decisional capacity and the role of the doctors (if the patient lacks capacity) are discussed. Recommendations are also made on how to better manage such situations.

Entities:  

Mesh:

Year:  2009        PMID: 19434342

Source DB:  PubMed          Journal:  Ann Acad Med Singapore        ISSN: 0304-4602            Impact factor:   2.473


  4 in total

1.  Assessing capacity in psychiatric patients with acute medical illness who refuse care.

Authors:  Marc Tunzi; Jeffrey P Spike
Journal:  Prim Care Companion CNS Disord       Date:  2014-11-27

Review 2.  Dialysis decisions concerning cognitively impaired adults: a scoping literature review.

Authors:  Jordan A Parsons; Jonathan Ives
Journal:  BMC Med Ethics       Date:  2021-03-05       Impact factor: 2.652

3.  End-of-life care for people with severe mental illness: mixed methods systematic review and thematic synthesis of published case studies (the MENLOC study).

Authors:  Michael Coffey; Deborah Edwards; Sally Anstey; Paul Gill; Mala Mann; Alan Meudell; Ben Hannigan
Journal:  BMJ Open       Date:  2022-02-22       Impact factor: 2.692

4.  The Full Spectrum of Clinical Ethical Issues in Kidney Failure. Findings of a Systematic Qualitative Review.

Authors:  Hannes Kahrass; Daniel Strech; Marcel Mertz
Journal:  PLoS One       Date:  2016-03-03       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.